Article Information
History
- July 25, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zhijie Deng1,*,
- Fanglu Chen2,*,
- Shunshun Peng1,
- Lin Gui1,
- Yangjin Huang3,
- Jing Chen1,
- Anhua Wei1,** and
- Yufeng Ding1,**
- 1Department of Pharmacy, Tongji Hospital, Tongji medical College, Huazhong University of Science and Technology, Wuhan, China
- 2School of Statistics, Renmin University of China, Beijing, China
- 3School of Management, Huazhong University of Science and Technology, Wuhan, China
- ↵**Correspondence: An-Hua Wei, Email: ahwei0716{at}163.com Tel: +86 186 7275 5470, Yu-Feng Ding, Email: yfding463{at}163.com Tel: +86 139 7162 9428
↵* Contributed equally as co-first authors
Posted July 25, 2024.
Could Chinese cardiovascular chronic conditions patients gain benefits from pharmaceutical services? A multilevel meta-analysis
